Overview

Histaminergic Basis of Fatigue in Multiple Sclerosis

Status:
Withdrawn
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to identify a way to improve the feeling of exhaustion that patients might experience because of Multiple Sclerosis (MS).
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami
Treatments:
Histamine